Exane Derivatives’s Sensient Technologies SXT Stock Holding History

Exane Derivatives’s Portfolio SXT Stock Details SXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$124K	Sell	1,539 -6,673	-81%	-$553K	0.07%	244
2022 Q1	$689K	Buy	8,212 +6,879	+516%	+$580K	0.19%	137
2021 Q4	$133K	Buy	1,333 +377	+39%	+$36.7K	0.03%	408
2021 Q3	$87.1K	Buy	+956	New	+$83.7K	0.02%	539
2021 Q1	–	Sell	-13,717	Closed	-$1.01M	–	965
2020 Q4	$1.01M	Sell	13,717 -1,396	-9%	-$97.4K	0.3%	86
2020 Q3	$873K	Buy	+15,113	New	+$834K	0.25%	98

Other funds holding SXT

Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's SXT Position: Q2 2022 in Review

Exane Derivatives reduced its Sensient Technologies (SXT) stake by 81% in Q2 2022, selling an estimated $553K and leaving 1,539 shares worth $124K. The position accounts for 0.07% of the portfolio, ranked #244.

Exane Derivatives first reported a position in SXT in Q3 2020 and has held it in 6 quarters since. The position peaked at $1.01M in Q4 2020. 251 funds tracked by Wall St. Rank hold SXT as of Q2 2022.

Exane Derivatives held 1,539 shares of Sensient Technologies worth $124K as of Q2 2022.
Exane Derivatives sold 6,673 Sensient Technologies shares in Q2 2022, an estimated $553K.
Sensient Technologies made up 0.07% of Exane Derivatives's portfolio in Q2 2022, its #244 holding.
Exane Derivatives first reported a position in Sensient Technologies in Q3 2020 and has held it in 6 quarters since.
Exane Derivatives's Sensient Technologies position peaked at $1.01M in Q4 2020.
251 funds tracked by Wall St. Rank held Sensient Technologies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.